blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4314059

EP4314059 - HUMANIZED ANTIBODIES AGAINST PAIRED HELICAL FILAMENT TAU AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  05.01.2024
Database last updated on 22.08.2024
FormerThe international publication has been made
Status updated on  30.09.2022
Formerunknown
Status updated on  13.04.2022
Most recent event   Tooltip31.05.2024Change: Validation statespublished on 03.07.2024  [2024/27]
31.05.2024Change - extension statespublished on 03.07.2024  [2024/27]
Applicant(s)For all designated states
Janssen Biotech, Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
[2024/06]
Inventor(s)01 / NANJUNDA, Rupesh
Horsham, Pennsylvania 19044 / US
02 / CHOWDHURY, Partha
Spring House, Pennsylvania 19477 / US
03 / SHA, Fern
Spring House, Pennsylvania 19477 / US
 [2024/06]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2024/06]
Application number, filing date22714553.925.03.2022
[2024/06]
WO2022IB52763
Priority number, dateUS202163166524P26.03.2021         Original published format: US 202163166524 P
US202263269225P11.03.2022         Original published format: US 202263269225 P
[2024/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022201122
Date:29.09.2022
Language:EN
[2022/39]
Type: A1 Application with search report 
No.:EP4314059
Date:07.02.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 29.09.2022 takes the place of the publication of the European patent application.
[2024/06]
Search report(s)International search report - published on:EP29.09.2022
ClassificationIPC:C07K16/28, C07K16/18, A61P25/28, A61K39/395
[2024/06]
CPC:
A61P25/28 (EP,IL,KR); C07K16/18 (EP,IL,KR,US); C07K16/2881 (EP,IL,KR,US);
C07K16/2896 (EP,IL,KR,US); C12N15/63 (US); G01N33/6896 (KR);
A61K2039/505 (EP,IL,KR); C07K2317/24 (EP,IL,KR,US); C07K2317/31 (EP,IL,KR);
C07K2317/34 (EP,IL,KR,US); C07K2317/565 (US); C07K2317/622 (EP,IL,KR,US);
C07K2317/92 (EP,IL,KR,US); C07K2319/00 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/06]
TitleGerman:HUMANISIERTE ANTIKÖRPER GEGEN TAU MIT GEPAARTEM SPIRALFÖRMIGEM FILAMENT UND VERWENDUNGEN DAVON[2024/06]
English:HUMANIZED ANTIBODIES AGAINST PAIRED HELICAL FILAMENT TAU AND USES THEREOF[2024/06]
French:ANTICORPS HUMANISÉS DIRIGÉS CONTRE LE FILAMENT HÉLICOÏDAL TAU APPARIÉ ET LEURS UTILISATIONS[2024/06]
Entry into regional phase26.10.2023National basic fee paid 
26.10.2023Designation fee(s) paid 
26.10.2023Examination fee paid 
Examination procedure26.10.2023Amendment by applicant (claims and/or description)
26.10.2023Examination requested  [2024/06]
26.10.2023Date on which the examining division has become responsible
Fees paidRenewal fee
15.02.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2013096380  (JANSSEN BIOTECH INC [US]);
 [XYI]WO2020037311  (UNIV FLORIDA [US]);
by applicantUS4676980
 US4816567
 WO9007861
 WO9202190
 WO9222653
 WO9308829
 US5225539
 WO9316185
 US5530101
 US5571894
 US5585089
 US5587458
 US5641870
 US5693762
 US5693761
 US5731168
 US5821337
 US5869619
 US5877293
 US5886152
 US5895205
 US5929212
 WO9951642
 US6054297
 WO0042072
 US6180370
 US6407213
 US2002161201
 US6548640
 US6632927
 US6639055
 WO2004006955
 US6750325
 WO2005040219
 US2005238646
 US2006025576
 US2006073137
 US2008069820
 WO2009089004
 US7657380
 US2010261620
 US9371376
 US9834596
 US10457742
 US20200630360
 US19610630359
 US19390631664
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.